Examples of Recent Technology Transfer Initiatives

  • Greg Winter – Creation of Bicycle Therapeutics (2009) to develop a novel technology platform for the creation of a new generation of biotherapeutics.
  • Brad Amos – Setting up of Mesolens Ltd (2009) to develop the technology behind Mesolens microscopy, a new type of imaging that can reach deeper into solid tissues such as embryos or tumours.
  • Chris Russo and Lori Passmore – Commercial licensing of gold EM support grids (UltrAuFoil®) to Quantifoil (2015)
  • Philipp Holliger – Commercial licensing of an in vitro compartmentalization (IVC) technique to a large biotech company (2017)
  • Minmin Yu, Adam Fowle, Wai-ching Hon and Andrew Leslie – Commercial licensing of CombiPuckTM for X-ray crystallography to Mitegen (2017)
  • Ernesto Giabatti and Marco Tripodi – Self-inactivating Rabies virus (SiR) – a new tool to study neural networks (2017)
  • Fabrice Gorrec – Morpheus® III screen exclusively licensed to Molecular Dimensions (2017)
  • Dean Clift, Melina Schuh and Leo James – Trim AwayTM a unique method for the rapid degradation of proteins (2017)
  • Mike Gait – Creation of PepGen (2018), a spin-out company which will develop cell penetrating peptides for the treatment of rare genetic disorders
  • Anne Bertolotti – Licensing of Raphin1 and phosphatase inhibitors technology to CamPhos Therapeutics (2018)
  • Michel Goedert – Tau Transgenic Mice (continued success since 2002)